MANNING & NAPIER ADVISORS LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 62039
Fairport, NY
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,025,250
-$97,476,562 QoQ
Shares Held
2,064
-99.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#822
of 1,705 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MANNING & NAPIER ADVISORS LLC holds $1,077,898 across 13 Biotechnology names. VRTX ranks #1 (95.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
2,064 | $1,025,250 | |
| 2 | INCY |
Incyte Corp
|
92 | $10,429 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
170 | $9,727 | |
| 4 | INVA |
Innoviva, Inc.
|
353 | $8,016 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
26 | $4,869 | |
| 6 | MRNA |
Moderna, Inc.
|
56 | $3,921 | |
| 7 | TECH |
BIO-TECHNE Corp
|
52 | $3,673 | |
| 8 | EXEL |
Exelixis, Inc.
|
55 | $2,992 |
All Filings in VRTX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,025,250 | 2,064 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $98,501,812 | 220,589 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $193,858,096 | 427,603 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $185,959,288 | 474,822 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $103,989,816 | 233,580 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $113,985,060 | 235,108 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $60,455,740 | 150,126 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $72,441,325 | 155,761 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $74,213,375 | 158,332 | Shares | Sole | 2024-07-11 | |
| No filing history on record for this holder in this stock. | ||||||